Advantages of positron emission tomography-computed tomography imaging in esophageal squamous cell carcinoma

被引：9
|
作者：
Wang, F. [1 ]
Shen, L. -Y. [1 ]
Ma, S. -H. [1 ]
Li, N. [2 ]
Yang, Z. [2 ]
Chen, K. -N. [1 ]
机构：
[1] Peking Univ, Canc Hosp & Inst, Dept Thorac Surg 1, Key Lab Carcinogenesis & Translat Res, Beijing 100142, Peoples R China
[2] Peking Univ, Canc Hosp & Inst, Dept Nucl Med, Key Lab Carcinogenesis & Translat Res, Beijing 100142, Peoples R China
来源：
DISEASES OF THE ESOPHAGUS | 2013年 / 26卷 / 08期
基金：
北京市自然科学基金;
关键词：
esophageal squamous cell carcinoma; metastasis; PET-CT; recurrence; response evaluation; F-18-FDG PET/CT; CANCER; CT;
D O I：
10.1111/j.1442-2050.2012.01407.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
To explore the value of positron emission tomography-computed tomography (PET-CT) scan in esophageal squamous cell carcinoma (ESCC), we retrospectively summarize the results of PET-CT scan from 118 patients, with ESCC who underwent PET-CT scan in the different courses during treatment. Then, the results of PET-CT scan plus other conventional methods were analyzed to identify the value of PET-CT scan in diagnosis, staging, response evaluation, monitoring recurrence, and metastasis following treatment. It is suggested that PET-CT scan possess high value in diagnosis and gives more favorable indication in N and M staging. PET-CT scan should be translated into routine surveillance for postoperation follow up and is one of more helpful evaluators of response to chemoradiotherapy or chemotherapy.
引用
收藏
页码：832 / 837
页数：6
相关论文
共 50 条
  • [21] Right intraventricular metastasis of lung squamous cell carcinoma detected on 18F-fluorodeoxyglucose positron emission tomography-computed tomography
    Ahsino, Fenna
    Zegmout, Adil
    Souhi, Hicham
    Hanane, ElOuazzani H.
    Rhorfi, Ismail
    Abid, Ahmed
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2021, 36 (04): : 459 - 461
  • [22] Positron emission tomography-computed tomography patient management and workflow
    Faasse, Todd
    Shreve, Paul
    SEMINARS IN ULTRASOUND CT AND MRI, 2008, 29 (04) : 277 - 282
  • [23] Significance of positron emission tomography-computed tomography in CUP syndromes
    Schreckenberger, Mathias
    ONKOLOGE, 2021, 27 (07): : 637 - 641
  • [24] Positron Emission Tomography-Computed Tomography Parameters Predict Efficacy of Immunotherapy in Head and Neck Squamous Cell Carcinomas
    Zhang, Songtao
    Zhang, Runfang
    Gong, Wenbo
    Wang, Chao
    Zeng, Chen
    Zhai, Yifei
    Fang, Qigen
    Dai, Liyuan
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [25] Protocol considerations for thoracic positron emission tomography-computed tomography
    Shyn, Paul B.
    SEMINARS IN ULTRASOUND CT AND MRI, 2008, 29 (04) : 242 - 250
  • [26] Pediatric positron emission tomography-computed tomography protocol considerations
    Nadel, Helen R.
    Shulkin, Barry
    SEMINARS IN ULTRASOUND CT AND MRI, 2008, 29 (04) : 271 - 276
  • [27] Fludeoxyglucose positron emission tomography-computed tomography in limbic encephalitis
    Patil, Sushanti
    Lele, Vikram
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2014, 29 (04): : 282 - 283
  • [28] Role of Positron Emission Tomography-Computed Tomography in Pulmonary Neoplasms
    Shreve, Paul
    Faasse, Todd
    RADIOLOGIC CLINICS OF NORTH AMERICA, 2013, 51 (05) : 767 - +
  • [29] Therapy Response Evaluation with Positron Emission Tomography-Computed Tomography
    Segall, George M.
    SEMINARS IN ULTRASOUND CT AND MRI, 2010, 31 (06) : 490 - 495
  • [30] Combined positron emission tomography-computed tomography: The historical perspective
    Townsend, David W.
    SEMINARS IN ULTRASOUND CT AND MRI, 2008, 29 (04) : 232 - 235
12345